PubMed:33166950 / 2064-2185
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T40 | 51-54 | Disease | denotes | AIS | http://purl.obolibrary.org/obo/MONDO_0003218|http://purl.obolibrary.org/obo/MONDO_0019154 |
T42 | 112-120 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T18 | 15-16 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T15 | 86-88 | Chemical | denotes | MT | http://purl.obolibrary.org/obo/CHEBI_73614 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 0-121 | Sentence | denotes | There was also a significantly increased number of AIS patients with LVO who received MT, especially those with COVID-19. |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 0-121 | Sentence | denotes | There was also a significantly increased number of AIS patients with LVO who received MT, especially those with COVID-19. |
T19 | 0-121 | Sentence | denotes | There was also a significantly increased number of AIS patients with LVO who received MT, especially those with COVID-19. |